Cargando…
Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study
Idiopathic inflammatory myopathies (IIM) are rare connective tissue diseases, which can lead to internal organ involvement. IL-33/ST2 pathway is involved in the pathogenesis of numerous diseases including autoimmune disorders. IL-33 fulfils cardioprotective function, while soluble ST2 (sST2) is a de...
Autores principales: | Opinc, Aleksandra, Sarnik, Joanna, Brzezińska, Olga, Makowski, Marcin, Lewandowska-Polak, Anna, Makowska, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256085/ https://www.ncbi.nlm.nih.gov/pubmed/32222805 http://dx.doi.org/10.1007/s00296-020-04554-z |
Ejemplares similares
-
Underdiagnosis of cardiopulmonary involvement in patients with idiopathic inflammatory myopathies
por: Opinc, Aleksandra, et al.
Publicado: (2021) -
Critical roles of interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) in pulmonary disorders
por: Xu, Jiao, et al.
Publicado: (2022) -
The impact of COVID-19 and healthcare system changes on the well-being of rheumatic patients
por: Opinc, Aleksandra, et al.
Publicado: (2021) -
Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement
por: Iannazzo, Francesco, et al.
Publicado: (2022) -
The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
por: Allegra, Alessandro, et al.
Publicado: (2019)